Cargando…
Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129889/ https://www.ncbi.nlm.nih.gov/pubmed/37124689 http://dx.doi.org/10.21037/hbsn-23-91 |
| _version_ | 1785030853395480576 |
|---|---|
| author | Merle, Philippe |
| author_facet | Merle, Philippe |
| author_sort | Merle, Philippe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10129889 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101298892023-04-27 Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma Merle, Philippe Hepatobiliary Surg Nutr Editorial AME Publishing Company 2023-03-27 2023-04-10 /pmc/articles/PMC10129889/ /pubmed/37124689 http://dx.doi.org/10.21037/hbsn-23-91 Text en 2023 Hepatobiliary Surgery and Nutrition. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Merle, Philippe Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma |
| title | Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma |
| title_full | Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma |
| title_fullStr | Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma |
| title_full_unstemmed | Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma |
| title_short | Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma |
| title_sort | lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129889/ https://www.ncbi.nlm.nih.gov/pubmed/37124689 http://dx.doi.org/10.21037/hbsn-23-91 |
| work_keys_str_mv | AT merlephilippe lenvatinibapplicabilityinthetherapeuticstrategyofpatientswithhepatocellularcarcinoma |